The Santa Casa da Misericordia hospital of Porto Alegre, Brazil, will expand Clinerion’s network of partner hospitals in Brazil. Patients from the hospital’s seven clinics will gain access to leading-edge, innovative medical treatment via Clinerion’s Patient Network Explorer platform.
On the Patient Network Explorer, patients of Santa Casa da Misericordia will have the opportunity to be matched to international clinical trials being run by pharmaceutical companies and clinical investigators around the world. Participation in these trials enhances their access to leading-edge, innovative medical treatments and care.
Users of Patient Network Explorer will gain an expanded insight into the patient population in Brazil and be able to make strategic drug development decisions based on real-time, real-world data.
“Together with our partner, iHealth, Clinerion is in the process of a significant push to encompass coverage of the majority of patients in Brazil,” says Clinerion CEO Ian Rentsch. “Santa Casa da Misericordia represents an important addition to Clinerion’s network of partner hospitals in the country, the region, and the world.”
“Santa Casa has a long tradition in Clinical Research and the Clinerion / iHealth Patient Network Explore will help us maintain leadership in this area,” says Dr. Jorge Hetzel, Medical Director for Teaching and Research.
About Santa Casa da Misericordia
Santa Casa da Misericordia is a general hospital that runs seven clinics with 1,023 beds and 1,747 doctors. The hospital takes in average ca. fifty thousand in-patients per year and performs 6.4 million procedures. With 294 Academic studies and 78 multicentric trials, Santa Casa is the leading research institution in Rio Grande do Sul state. Santa Casa da Misericordia website: www.santacasa.org.br